Houlihan Lokey Q1 revenue falls 15% driven by Middle East conflict
HLI•Analyst coverage and valuation
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell".
The average consensus recommendation for the investment banking & brokerage services peer group is "buy."
Wall Street's median 12-month price target for Houlihan Lokey Inc is $163.50, about 12.4% above its July 28 closing price of $145.47.
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 17 three months ago.
Outlook calls headwinds temporary
Houlihan Lokey said the headwinds in Corporate Finance are expected to be temporary, though the company sees uncertainty over the timing of a recovery from the current headwinds.
The company expects improved performance for the balance of the year.
Q1 revenue and earnings miss estimates
Houlihan Lokey's fiscal first-quarter revenue fell 15% and missed analyst expectations. Adjusted net income for the quarter also missed analyst expectations.
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q1 Revenue | Miss | $511 mln | $629.96 mln (8 Analysts) |
| Q1 EPS | $1.15 | ||
| Q1 Adjusted Net Income | Miss | $91 mln | $121.42 mln (5 Analysts) |
| Q1 Net Income | $78 mln |
Corporate finance weakness weighs on results
Related News
HWH International agrees to sell 20,000,000 shares, warrants in $10 million private placement with Smart Dynamics Technology
Ambiq Micro shares set to start trading on SGX in secondary listing by introduction after NYSE close at US$ 57.26
